Results 381 to 390 of about 191,621 (404)

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

NTRK fusion-positive cancers and TRK inhibitor therapy

Nature Reviews Clinical Oncology, 2018
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon   +2 more
exaly  

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel, Diego Chowell, Timothy A Chan   +2 more
exaly  

Appraising iniparib, the PARP inhibitor that never was—what must we learn?

Nature Reviews Clinical Oncology, 2013
Joaquin Mateo, Michael Ong, David S P Tan   +2 more
exaly  

Efficacy of Vonoprazan for Proton Pump Inhibitor-Resistant Reflux Esophagitis

Digestion, 2017
Shintaro Hoshino, Noriyuki Kawami, Nana Takenouchi, M. Umezawa, Y. Hanada, Yoshimasa Hoshikawa, T. Kawagoe, Hirohito Sano, Y. Hoshihara, T. Nomura, K. Iwakiri   +10 more
semanticscholar   +1 more source

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cell, 2020
Markus Hoffmann, Nadine Krüger, Tobias S Schiergens   +2 more
exaly  

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Nature Medicine, 2018
Yuting Sun, Jeffrey J Ackroyd, Stefan O Ciurea   +2 more
exaly  

The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy

Nature Reviews Cancer, 2008
Ludger Hengst, Joyce M Slingerland
exaly  

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

Nature, 2009
Michael A Milhollen, James J Garnsey, Lawrence R Dick   +2 more
exaly  

High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia

Journal of Pediatric Gastroenterology and Nutrition - JPGN, 2016
C. Gutiérrez‐Junquera, S. Fernández-Fernández, M. Cilleruelo, A. Rayo, L. Echeverría, S. Quevedo, T. Bracamonte, E. Román   +7 more
semanticscholar   +1 more source